Aspirin use is associated with decreased inpatient mortality in patients with COVID-19: A meta-analysis

Thromboembolism is a major cause of death in patients who suffer from COVID-19. Studies examining the effects of aspirin (ASA) on mortality relating to this phenomenon have showed conflicting results with varying degrees and certainties of evidence. We performed an aggregate data meta-analysis of fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivasan, Aswin, Brown, Jonathan, Krishnamani, Pavitra Parimala, Cornett, Brendon, Kesavan, Ramesh Babu, Sarva, Siva T., Raza, Syed Arman, Kayani, Waleed Tallat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365516/
https://www.ncbi.nlm.nih.gov/pubmed/35971534
http://dx.doi.org/10.1016/j.ahjo.2022.100191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365516/
https://www.ncbi.nlm.nih.gov/pubmed/35971534
http://dx.doi.org/10.1016/j.ahjo.2022.100191

Ejemplares similares